title: Combined hepatitis B immune globulin and vaccine for postexposure prophylaxis of accidental hepatitis B virus infection in hemodialysis staff members: comparison with immune globulin without vaccine in historical controls.
abstract: Twenty-three staff members serving in a hemodialysis unit were exposed accidentally to needlestick contaminated with blood containing hepatitis B surface antigen and hepatitis B e antigen, as well as high levels of DNA polymerase activity (greater than 100 cpm). They received hepatitis B vaccine (20 micrograms) simultaneously with hepatitis B immune globulin (5 ml, 200 IU per ml) within 48 hr after the exposure, and the vaccination was repeated at 1 and 3 months. The protective efficacy was compared with that in a past study in the same unit in which 33 members were given hepatitis B immune globulin alone within 48 hr after the exposure to blood with similarly high levels of DNA polymerase activity. No differences were noted in age or sex between the staff members who were vaccinated and those who were not, nor were there any differences between their inocula in the titers of hepatitis B virus markers. During 12 months after the accident, only one (4%) of the 23 vaccinated members contracted hepatitis B virus infection, at a frequency significantly lower than 11 (33%) of the 33 members who did not receive vaccine (p less than 0.02). These results indicate that hepatitis B vaccine, when given in combination with hepatitis B immune globulin, is efficacious for postexposure immunoprophylaxis of accidental infection.
authors.affiliation: Masuko Hospital, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Mitsui
authors.forename: K
authors.initials: K
authors.lastname: Iwano
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: C
authors.initials: C
authors.lastname: Yamazaki
authors.forename: K
authors.initials: K
authors.lastname: Masuko
authors.forename: F
authors.initials: F
authors.lastname: Tsuda
authors.forename: S
authors.initials: S
authors.lastname: Aihara
authors.forename: Y
authors.initials: Y
authors.lastname: Akahane
authors.forename: Y
authors.initials: Y
authors.lastname: Miyakawa
authors.forename: M
authors.initials: M
authors.lastname: Mayumi
mesh_terms: D000328:Adult; D004259:DNA-Directed DNA Polymerase / Q000032:analysis; D005260:Female; D006436:Hemodialysis Units, Hospital; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006511:Hepatitis B Antigens / Q000032:analysis; D017325:Hepatitis B Vaccines; D006757:Hospital Units; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage*; D007564:Japan; D008297:Male; D009784:Occupational Diseases / Q000517:prevention & control*; D010564:Personnel, Hospital; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage*
chemical_list: D006511:Hepatitis B Antigens; D017325:Hepatitis B Vaccines; D007136:Immunoglobulins; D014761:Viral Hepatitis Vaccines; D004259:DNA-Directed DNA Polymerase; C045213:hepatitis B hyperimmune globulin